 |
BioWorld-International-2004-02-04
Cyclacel's Fourth Round Gets $39M For Cell Cycle Inhibitors
Cyclacel's Fourth Round Gets $39M For Cell Cycle Inhibitors
LONDON - Cyclacel Ltd. raised £21.3 million (US$39 million) in an oversubscribed fourth round of private funding, bringing its total private equity raised to date to $123 million. (BioWorld International)